EFFECTS OF COPANLISIB, A NOVEL PAN-CLASS I PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR, ON METFORMIN PHARMACOKINETICS AND PHARMACODYNAMICS IN HEALTHY SUBJECTS.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要